MicroBioSensor
MicroBioSensor is a medical device company developing disposable point-of-care safety monitors for detecting microbial infection. Their technology enables rapid, simple, and inexpensive diagnostics to identify infections and antibiotic sensitivities, improving patient care and combating antimicrobial resistance. They focus on addressing unmet needs in infection diagnosis for conditions such as kidney disease and liver disease, and aim to empower patients with easy-to-use point-of-care diagnostics.
Industries
Nr. of Employees
small (1-50)
MicroBioSensor
Products
QuickCheck (point-of-care leukocyte detection for peritoneal dialysis)
A disposable point-of-care diagnostic intended to provide instant identification of leukocyte levels to support peritoneal dialysis professionals in early detection of infection.
QuickCheck SBP (in-clinic test for spontaneous bacterial peritonitis)
An in-clinic disposable diagnostic intended to confirm spontaneous bacterial peritonitis (SBP) in ascitic fluid rapidly (seconds), reducing reliance on >24-hour central lab testing.
QuickCheck (point-of-care leukocyte detection for peritoneal dialysis)
A disposable point-of-care diagnostic intended to provide instant identification of leukocyte levels to support peritoneal dialysis professionals in early detection of infection.
QuickCheck SBP (in-clinic test for spontaneous bacterial peritonitis)
An in-clinic disposable diagnostic intended to confirm spontaneous bacterial peritonitis (SBP) in ascitic fluid rapidly (seconds), reducing reliance on >24-hour central lab testing.
Services
Collaboration with CMOs, medical device firms and suppliers to establish flexible, scalable manufacturing and supply-chain arrangements for disposable diagnostics.
Engagement with patients and healthcare professionals during design to ensure devices meet clinical workflow and usability requirements.
Collaboration with CMOs, medical device firms and suppliers to establish flexible, scalable manufacturing and supply-chain arrangements for disposable diagnostics.
Engagement with patients and healthcare professionals during design to ensure devices meet clinical workflow and usability requirements.
Expertise Areas
- Point-of-care diagnostics
- Infection diagnostics and early warning systems
- Clinical diagnostics for peritoneal dialysis and ascites (peritonitis / SBP)
- Urinary tract infection diagnostics
Key Technologies
- Biosensor-based infection detection
- Point-of-care in vitro diagnostics (IVDs)
- Rapid leukocyte/WBC detection assays
- Rapid antimicrobial susceptibility testing (rapid AST)
News & Updates
Microbiosensor has successfully applied for and won a £100,000 development contract in a competitive tender organised by The Small Business Research Initiative for Healthcare (SBRI Healthcare). The project aims to develop a rapid diagnostic device for urinary tract infections to reduce A&E admissions.
Microbiosensor was announced as one of the successful companies to win an award in the first round of GMAHSN’s new Innovation Funds, focusing on innovative healthcare solutions.
Microbiosensor has successfully applied for and won a £100,000 development contract in a competitive tender organised by The Small Business Research Initiative for Healthcare (SBRI Healthcare).
Microbiosensor was awarded the Bionow Investment Deal of the Year Award, recognizing excellence and achievement in the biotech sector.
Microbiosensor secured £1.4 million in equity finance through the Northern Powerhouse Investment Fund, supporting its development activities.
Microbiosensor was selected by SBRI Healthcare for a second tranche of investment to develop products that reduce pressure on urgent and emergency care services.
Microbiosensor has successfully applied for and won a £100,000 development contract in a competitive tender organised by The Small Business Research Initiative for Healthcare (SBRI Healthcare). The project aims to develop a rapid diagnostic device for urinary tract infections to reduce A&E admissions.
Microbiosensor was announced as one of the successful companies to win an award in the first round of GMAHSN’s new Innovation Funds, focusing on innovative healthcare solutions.
Microbiosensor has successfully applied for and won a £100,000 development contract in a competitive tender organised by The Small Business Research Initiative for Healthcare (SBRI Healthcare).
Microbiosensor was awarded the Bionow Investment Deal of the Year Award, recognizing excellence and achievement in the biotech sector.
Microbiosensor secured £1.4 million in equity finance through the Northern Powerhouse Investment Fund, supporting its development activities.
Microbiosensor was selected by SBRI Healthcare for a second tranche of investment to develop products that reduce pressure on urgent and emergency care services.